| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +385K | 100% | $2.35 | +$904K |
| Sells | 0 | ||||
| Net | +1 | +385K | 100% | +$904K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| SHV Management Services, LLC | 10%+ Owner | $3.4M | Jun 13, 2022 | ||
| Biotech Target N V | 10%+ Owner | $3.32M | +$904K | +37.3% | Apr 2, 2024 |
| Kevin M. Lalande | Director, 10%+ Owner | $2.49M | Apr 2, 2024 | ||
| Sean McLennan | Chief Financial Officer (interim) and Treasurer | $14.1K | Jun 16, 2022 | ||
| Eric E. Poma | Chief Executive Officer and Chief Scientific Officer, Director | Jan 23, 2024 | |||
| Roger J. Waltzman | Chief Medical Officer | Feb 15, 2023 | |||
| Jonathan Lanfear | Director | Oct 27, 2023 | |||
| Harold E. Selick | Director | Oct 27, 2023 | |||
| Jason S. Kim | Chief Financial Officer | Jan 23, 2024 | |||
| Gabriela Gruia | Director | Oct 27, 2023 | |||
| Dave Hoffmann | Director | Oct 27, 2023 | |||
| Maurizio Voi | Chief Medical Officer | Jan 23, 2024 | |||
| (Corsee) Sanders Corazon | Director | Oct 27, 2023 | |||
| David Hirsch | Director | Jun 3, 2022 | |||
| Scott D. Morenstein | Director | Jun 3, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|